Does CABOZANTINIB S-MALATE Cause Mucosal inflammation? 282 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 282 reports of Mucosal inflammation have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.7% of all adverse event reports for CABOZANTINIB S-MALATE.
282
Reports of Mucosal inflammation with CABOZANTINIB S-MALATE
0.7%
of all CABOZANTINIB S-MALATE reports
23
Deaths
51
Hospitalizations
How Dangerous Is Mucosal inflammation From CABOZANTINIB S-MALATE?
Of the 282 reports, 23 (8.2%) resulted in death, 51 (18.1%) required hospitalization, and 3 (1.1%) were considered life-threatening.
Is Mucosal inflammation Listed in the Official Label?
Yes, Mucosal inflammation is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.
What Other Side Effects Does CABOZANTINIB S-MALATE Cause?
Diarrhoea (8,282)
Fatigue (6,819)
Off label use (5,245)
Nausea (4,341)
Decreased appetite (4,076)
Blood pressure increased (2,939)
Malignant neoplasm progression (2,718)
Palmar-plantar erythrodysaesthesia syndrome (2,706)
Weight decreased (2,657)
Stomatitis (2,560)
What Other Drugs Cause Mucosal inflammation?
METHOTREXATE (3,352)
CYCLOPHOSPHAMIDE (2,535)
DOXORUBICIN (1,939)
VINCRISTINE (1,594)
ETOPOSIDE (1,591)
FLUOROURACIL (1,481)
RITUXIMAB (1,364)
CYTARABINE (1,337)
CAPECITABINE (1,262)
CARBOPLATIN (1,259)
Which CABOZANTINIB S-MALATE Alternatives Have Lower Mucosal inflammation Risk?
CABOZANTINIB S-MALATE vs CAFFEINE
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL
CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL
CABOZANTINIB S-MALATE vs CALCIFEDIOL
CABOZANTINIB S-MALATE vs CALCIPOTRIENE